Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue
References (20)
- et al.
Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species
Prostaglandins
(1978) - et al.
Identification of platelet receptors for prostaglandin I2 and D2
J. Biol. Chem.
(1979) - et al.
Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1α on the rat gastric mucosa and
Prostaglandins
(1978) - et al.
A comparison of the vasodepressor effects of the cyclic endoperoxides PGG2 and PGH2 with those of PGD2 and PGE2 in hypertensive and normotensive rats
Eur. J. Pharamacol.
(1976) - et al.
Cardiovascular effetfs of prostaglandins in D3 and D2 in anaesthetised dogs
Prostaglandins
(1981) - et al.
Studies on the mechanisms involved in the fate of prostacyclin (PGI2) and 6-keto-PGF1α in pulmonary circulation
Prostaglandins
(1978) - et al.
Desensitization of prostaglandin-activated platelet adenylate cyclase
Prostaglandins
(1979) - et al.
An enzyme isolated from arteries transforms prostaglandin endeperoxides to an unstable substance that inhibits platelet aggregation
Nature
(1976) - et al.
Prostaglandin D2 inhibits the aggregation of human platelets
Thromb. Res.
(1974) - et al.
Selective binding site for [3H] prostacyclin on platelets
J. Clin. Invest.
(1979)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1983 Published by Elsevier Inc.